Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.07594 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.83606 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.84657 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.74423 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.77689 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.02016 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.41642 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.84695 | 64 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.79514 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.7923 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.85611 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.79376 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.04095 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.85831 | 64 |